Dimensional Fund Advisors LP Has $88.20 Million Position in Veralto Co. (NYSE:VLTO)

Dimensional Fund Advisors LP boosted its holdings in shares of Veralto Co. (NYSE:VLTO - Free Report) by 21.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 865,943 shares of the company's stock after buying an additional 153,814 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.35% of Veralto worth $88,197,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. raised its stake in Veralto by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 29,347,185 shares of the company's stock valued at $2,989,011,000 after acquiring an additional 146,234 shares during the period. Amundi lifted its stake in shares of Veralto by 2.3% during the 4th quarter. Amundi now owns 7,169,702 shares of the company's stock worth $731,084,000 after buying an additional 158,342 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Veralto by 12.5% during the 4th quarter. Geode Capital Management LLC now owns 6,601,676 shares of the company's stock worth $670,781,000 after buying an additional 733,056 shares during the period. Pictet Asset Management Holding SA grew its stake in Veralto by 1.2% in the 4th quarter. Pictet Asset Management Holding SA now owns 4,764,889 shares of the company's stock valued at $485,304,000 after buying an additional 54,795 shares during the last quarter. Finally, Invesco Ltd. raised its holdings in Veralto by 9.7% in the 4th quarter. Invesco Ltd. now owns 4,541,367 shares of the company's stock valued at $462,538,000 after acquiring an additional 401,228 shares during the period. Institutional investors own 91.28% of the company's stock.

Veralto Price Performance

NYSE:VLTO traded down $1.84 during mid-day trading on Thursday, reaching $94.06. The stock had a trading volume of 1,421,240 shares, compared to its average volume of 1,482,863. Veralto Co. has a 12 month low of $83.87 and a 12 month high of $115.00. The stock has a market capitalization of $23.33 billion, a PE ratio of 28.16, a P/E/G ratio of 4.24 and a beta of 0.97. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.92 and a quick ratio of 1.69. The stock has a 50-day simple moving average of $94.76 and a two-hundred day simple moving average of $100.68.

Veralto (NYSE:VLTO - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.95 EPS for the quarter, topping analysts' consensus estimates of $0.87 by $0.08. The company had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.28 billion. Veralto had a return on equity of 49.29% and a net margin of 16.04%. Veralto's revenue was up 6.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.84 EPS. On average, equities analysts anticipate that Veralto Co. will post 3.66 earnings per share for the current year.

Veralto Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 30th. Investors of record on Monday, March 31st were given a dividend of $0.11 per share. This represents a $0.44 dividend on an annualized basis and a yield of 0.47%. The ex-dividend date was Monday, March 31st. Veralto's dividend payout ratio is 13.17%.

Insider Activity at Veralto

In other news, SVP Surekha Trivedi sold 590 shares of the company's stock in a transaction that occurred on Tuesday, April 1st. The stock was sold at an average price of $97.05, for a total value of $57,259.50. Following the completion of the transaction, the senior vice president now owns 10,011 shares of the company's stock, valued at $971,567.55. This represents a 5.57 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Jennifer Honeycutt sold 10,414 shares of Veralto stock in a transaction that occurred on Tuesday, February 25th. The stock was sold at an average price of $100.35, for a total transaction of $1,045,044.90. Following the sale, the chief executive officer now owns 104,496 shares in the company, valued at approximately $10,486,173.60. This represents a 9.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 32,889 shares of company stock valued at $3,223,740 in the last quarter. Insiders own 0.36% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on VLTO shares. Citigroup reduced their price objective on Veralto from $116.00 to $100.00 and set a "neutral" rating for the company in a report on Monday, April 14th. Stifel Nicolaus upped their price objective on Veralto from $102.00 to $104.00 and gave the company a "buy" rating in a report on Thursday. Royal Bank of Canada lifted their target price on Veralto from $103.00 to $104.00 and gave the stock a "sector perform" rating in a report on Thursday. Finally, Robert W. Baird upped their price target on shares of Veralto from $105.00 to $106.00 and gave the company a "neutral" rating in a research note on Thursday. Six analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, Veralto currently has a consensus rating of "Hold" and a consensus price target of $110.10.

Veralto Company Profile

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.